Alar Pharmaceuticals Inc. (TPEX:6785)

Taiwan · Delayed Price · Currency is TWD

191.00

+7.50 (4.09%)

Mar 6, 2026, 9:30 AM CST

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
New Drug Research and Development Department	5.82M	469.27M	800.00K		600.00K		500.00K
New Drug Research and Development Department Growth	-98.76%	58559.00%	-		-		-16.67%
Total	5.82M	469.27M	800.00K		600.00K		500.00K
Total Growth	-98.76%	58559.00%	-		-		-16.67%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Taiwan	-	800.00K	800.00K		600.00K		500.00K
Taiwan Growth	-	0%	-		-		-16.67%
United Kingdom	-	468.47M	-		-		-
United State	5.82M	-	-		-		-
Total	5.82M	469.27M	800.00K		600.00K		500.00K
Total Growth	-98.76%	58559.00%	-		-		-16.67%

Source: S&P Global Market Intelligence.